We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Jubbonti/Wyost

Australian Public Assessment Report

AusPAR

AusPAR: Jubbonti/Wyost [PDF, 423.67 KB]

AusPAR: Jubbonti/Wyost [DOCX, 395.72 KB]

Attachment: Product Information for Jubbonti [PDF, 339.76 KB]

Attachment: Product Information for Jubbonti [DOCX, 199.19 KB]

Attachment: Product Information for Wyost [PDF, 498.84 KB]

Attachment: Product Information for Wyost [DOCX, 591.8 KB]

Device/Product Name

Jubbonti/Wyost

Active ingredients

Denosumab

AusPAR Date

10 October 2024

Published

28 October 2024

Submission Number

PM-2023-03741-1-5

Submission Type

New biological medicine (Biosimilar)

Decision

Approved

Product types

Prescription medicines